ArticleKidney international reports2026
Association of Kidney Volume With Patient-Reported Outcomes in ADPKD.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Beyond Pain: Sarcopenia, Malnutrition, and Sex-Specific Body Image Distortion as Potential Additional Mediators of HRQOL Impairment in ADPKD.Kidney international reports · 2026Article
- Response to "Beyond Pain: Sarcopenia, Malnutrition, and Sex-Specific Body Image Distortion as Potential Additional Mediators of HRQOL Impairment in ADPKD".Kidney international reports · 2026Article
- The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD.Kidney international reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) may impose physical and emotional burdens, partly through enlarged kidneys. The association of health-related quality-of-life (HRQOL) with total kidney volume (TKV) remains unclear, particularly in combination with kidney function and pain status. Methods: Participants diagnosed with ADPKD were recruited between 2017 and 2023. We examined the associations of TKV, estimated glomerular filtration rate using the Chronic Kidney Disease Epidemiology Collaboration race-free creatinine equation (eGFR), and chronic kidney pain (Yes/No) with HRQOL (Short Form-36 [SF-36] scores) using multivariable linear regression. Factor analysis of mixed data (FAMD) was used to classify patients into clusters based on TKV, eGFR, and kidney pain; and their HRQOL was compared. Results: Of 456 participants, mean (SD) age was 47 (16) years, 216 (47%) were males, eGFR was 81 (27) ml/min per 1.73 m Conclusion: TKV is associated with physical health, independent of kidney pain and function, and with mental health (MH) indirectly through kidney pain. Alleviating kidney pain, preserving function, and limiting kidney enlargement in ADPKD may all help to improve HRQOL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.